These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 11856743)

  • 1. Activation of the c-Jun N-terminal kinase (JNK) signaling pathway is essential during PBOX-6-induced apoptosis in chronic myelogenous leukemia (CML) cells.
    Mc Gee MM; Campiani G; Ramunno A; Nacci V; Lawler M; Williams DC; Zisterer DM
    J Biol Chem; 2002 May; 277(21):18383-9. PubMed ID: 11856743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective induction of apoptosis by the pyrrolo-1,5-benzoxazepine 7-[[dimethylcarbamoyl]oxy]-6-(2-naphthyl)pyrrolo-[2,1-d] (1,5)-benzoxazepine (PBOX-6) in Leukemia cells occurs via the c-Jun NH2-terminal kinase-dependent phosphorylation and inactivation of Bcl-2 and Bcl-XL.
    Mc Gee MM; Greene LM; Ledwidge S; Campiani G; Nacci V; Lawler M; Williams DC; Zisterer DM
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1084-95. PubMed ID: 15143129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyrrolo-1,5-benzoxazepines induce apoptosis in chronic myelogenous leukemia (CML) cells by bypassing the apoptotic suppressor bcr-abl.
    Mc Gee MM; Campiani G; Ramunno A; Fattorusso C; Nacci V; Lawler M; Williams DC; Zisterer DM
    J Pharmacol Exp Ther; 2001 Jan; 296(1):31-40. PubMed ID: 11123359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrrolo-1,5-benzoxazepines: a new class of apoptotic agents.
    Zisterer DM; McGee MM; Campiani G; Ramunno A; Fattorusso C; Nacci V; Lawler M; Williams DC
    Biochem Soc Trans; 2001 Nov; 29(Pt 6):704-6. PubMed ID: 11709059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic mitogen-activated protein/extracellular signal-regulated kinase kinase/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr/Abl-expressing human leukemia cells.
    Yu C; Krystal G; Varticovksi L; McKinstry R; Rahmani M; Dent P; Grant S
    Cancer Res; 2002 Jan; 62(1):188-99. PubMed ID: 11782377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ceramide promotes apoptosis in chronic myelogenous leukemia-derived K562 cells by a mechanism involving caspase-8 and JNK.
    Nica AF; Tsao CC; Watt JC; Jiffar T; Kurinna S; Jurasz P; Konopleva M; Andreeff M; Radomski MW; Ruvolo PP
    Cell Cycle; 2008 Nov; 7(21):3362-70. PubMed ID: 18948750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.
    Wilson MB; Schreiner SJ; Choi HJ; Kamens J; Smithgall TE
    Oncogene; 2002 Nov; 21(53):8075-88. PubMed ID: 12444544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of extracellular signal-regulated kinase and c-Jun-NH(2)-terminal kinase but not p38 mitogen-activated protein kinases is required for RRR-alpha-tocopheryl succinate-induced apoptosis of human breast cancer cells.
    Yu W; Liao QY; Hantash FM; Sanders BG; Kline K
    Cancer Res; 2001 Sep; 61(17):6569-76. PubMed ID: 11522656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol induces apoptosis of human chronic myelogenous leukemia cells in vitro through p38 and JNK-regulated H2AX phosphorylation.
    Wu XP; Xiong M; Xu CS; Duan LN; Dong YQ; Luo Y; Niu TH; Lu CR
    Acta Pharmacol Sin; 2015 Mar; 36(3):353-61. PubMed ID: 25619392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-apoptotic effect of quercetin: intervention in the JNK- and ERK-mediated apoptotic pathways.
    Ishikawa Y; Kitamura M
    Kidney Int; 2000 Sep; 58(3):1078-87. PubMed ID: 10972672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor necrosis factor alpha-induced E-selectin expression is activated by the nuclear factor-kappaB and c-JUN N-terminal kinase/p38 mitogen-activated protein kinase pathways.
    Read MA; Whitley MZ; Gupta S; Pierce JW; Best J; Davis RJ; Collins T
    J Biol Chem; 1997 Jan; 272(5):2753-61. PubMed ID: 9006914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arsenic trioxide induces apoptosis in chronic myelogenous leukemia K562 cells: possible involvement of p38 MAP kinase.
    Shim MJ; Kim HJ; Yang SJ; Lee IS; Choi HI; Kim T
    J Biochem Mol Biol; 2002 Jul; 35(4):377-83. PubMed ID: 12296996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinoic acid inhibits induction of c-Jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo.
    Fisher GJ; Talwar HS; Lin J; Lin P; McPhillips F; Wang Z; Li X; Wan Y; Kang S; Voorhees JJ
    J Clin Invest; 1998 Mar; 101(6):1432-40. PubMed ID: 9502786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of apoptosis by shikonin through a ROS/JNK-mediated process in Bcr/Abl-positive chronic myelogenous leukemia (CML) cells.
    Mao X; Yu CR; Li WH; Li WX
    Cell Res; 2008 Aug; 18(8):879-88. PubMed ID: 18663379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early modifications in the expression of mitogen-activated protein kinase (MAPK/ERK), stress-activated kinases SAPK/JNK and p38, and their phosphorylated substrates following focal cerebral ischemia.
    Ferrer I; Friguls B; Dalfó E; Planas AM
    Acta Neuropathol; 2003 May; 105(5):425-37. PubMed ID: 12677442
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of ERK signaling evokes autocrine Fas-mediated death in arachidonic acid-treated human chronic myeloid leukemia K562 cells.
    Chen KC; Liu WH; Chang LS
    J Cell Physiol; 2010 Mar; 222(3):625-34. PubMed ID: 19927299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel pyrrolo-1,5-benzoxazepine, PBOX-21, potentiates the apoptotic efficacy of STI571 (imatinib mesylate) in human chronic myeloid leukaemia cells.
    Bright SA; Greene LM; Greene TF; Campiani G; Butini S; Brindisi M; Lawler M; Meegan MJ; Williams DC; Zisterer DM
    Biochem Pharmacol; 2009 Feb; 77(3):310-21. PubMed ID: 19014913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pyrrolo-1,5-benzoxazepine compounds display significant activity against resistant chronic myeloid leukaemia cells in vitro, in ex vivo patient samples and in vivo.
    Bright SA; McElligott AM; O'Connell JW; O'Connor L; Carroll P; Campiani G; Deininger MW; Conneally E; Lawler M; Williams DC; Zisterer DM
    Br J Cancer; 2010 May; 102(10):1474-82. PubMed ID: 20407438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The novel tubulin-targeting agent pyrrolo-1,5-benzoxazepine-15 induces apoptosis in poor prognostic subgroups of chronic lymphocytic leukemia.
    McElligott AM; Maginn EN; Greene LM; McGuckin S; Hayat A; Browne PV; Butini S; Campiani G; Catherwood MA; Vandenberghe E; Williams DC; Zisterer DM; Lawler M
    Cancer Res; 2009 Nov; 69(21):8366-75. PubMed ID: 19826055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JNK1/c-Jun and p38 alpha MAPK/ATF-2 pathways are responsible for upregulation of Fas/FasL in human chronic myeloid leukemia K562 cells upon exposure to Taiwan cobra phospholipase A2.
    Chen KC; Chiou YL; Chang LS
    J Cell Biochem; 2009 Oct; 108(3):612-20. PubMed ID: 19670268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.